Sanofi-Aventis forecasts vaccine sales to double
World News | December 18, 2009
PharmaTimes
Sanofi-Aventis expects to bring in 4 billion euros ($5.7 billion) in 2010 just from its vaccines, including its swine flu jab, the company announced in a presentation.
The company’s vaccine unit, Sanofi Pasteur, is aiming to double sales at the division by 2013 from 2.9 billion euros ($4.2 billion) in 2008. Indeed, it predicts the worldwide vaccines market will reach 23 billion euros ($33 billion) by 2013, up from 15 billion euros ($21.5 billion) in 2008.
The figures follow reports that suggest vaccines will have an increasing role in treating a variety of diseases in the future.
Sanofi currently has 18 vaccines in its product pipeline, including jabs to treat diseases Dengue fever, Clostridium difficile, rabies, and meningitis.
Click here to order a reprint of this news story.
Tags
vaccines
sanofi vaccine sales double
dengue fever
sanofi aventis
The views expressed in the following comments are not those of PharmaTimes or any connected third party and belong specifically to the individual who made that comment. We accept no liability for the comments made and always advise users to exercise caution.